Back to Directory Anne Coletti Email acoletti@fhi360.org Phone (919) 627-6445 Institution FHI 360 Title Clinical Research Manager Address FHI 360 359 Blackwell St. Suite 200 Durham, NC 27701 Request an Update Affiliated Studies IMPAACT 2039: Phase I/II Study of the Safety, Immunogenicity, and Efficacy of HIVconsvX Vaccines and Broadly Neutralizing Antibodies in Children Living with HIV DAIDS Number TBD Research Area Cure Study Status In Development 1077FF: PROMISE 1077FF DAIDS Number 10778 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed P1113: AERAS-404 TB Vaccine in BCG-Primed Infants DAIDS Number 11911 Research Area Tuberculosis Study Status Closed to Follow Up IMPAACT 2028: Long-Term Clinical, Immunologic, and Virologic Profiles of Children who Received Early Treatment for HIV DAIDS Number 38693 Research Area Cure Study Status Enrolling P1084s: Maternal Infant TDF Toxicity Safety DAIDS Number 10790 Research Area Complications & Comorbidities Study Status Closed to Follow Up Show All
IMPAACT 2039: Phase I/II Study of the Safety, Immunogenicity, and Efficacy of HIVconsvX Vaccines and Broadly Neutralizing Antibodies in Children Living with HIV DAIDS Number TBD Research Area Cure Study Status In Development
1077FF: PROMISE 1077FF DAIDS Number 10778 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed
P1113: AERAS-404 TB Vaccine in BCG-Primed Infants DAIDS Number 11911 Research Area Tuberculosis Study Status Closed to Follow Up
IMPAACT 2028: Long-Term Clinical, Immunologic, and Virologic Profiles of Children who Received Early Treatment for HIV DAIDS Number 38693 Research Area Cure Study Status Enrolling
P1084s: Maternal Infant TDF Toxicity Safety DAIDS Number 10790 Research Area Complications & Comorbidities Study Status Closed to Follow Up